MetaNovas

PharmaceuticalsSeries AShanghai, Chinametanovas.com

Latest round

Series A

Last raised

Mar 2026

Total raised

$10M

Investors

9

About MetaNovas

, dba MetaNovas, is a drug developer that mainly provides anti-ageing and metabolic drugs. It has an office in Silicon Valley, USA. The team members are from MIT, Stanford, Google, Facebook, and Kite Pharma., L'Oréal, and Beiersdorf AG. The company is developing anti-ageing drugs, metabolic drugs, and preventing neurodegenerative diseases based on deep learning, knowledge graph, and multi-omics analysis. It developed multiple platforms, including the Mete-KG knowledge graph platform, Meta-Omics analysis and computing platform, and Meta-NLP clinical and literature data mining platform. The drugs developed include anti-inflammatory peptides, anti-acne peptides, anti-wrinkle peptides, gum protection peptides, and vaginal care antimicrobial peptides. The company generates revenue by providing anti-ageing and metabolic drugs based on its technology platform.

Who invested in MetaNovas

9 investors across 4 rounds

See all investors in MetaNovas

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 9, 2026

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Dec 2, 2024

    Amount

    Undisclosed

    Investors

    Locked

  3. Angel

    Mar 31, 2022

    Amount

    $10M

    Investors

    Locked

  4. Series A

    Date not disclosed

    Amount

    Undisclosed

    Investors

    Locked

Questions about MetaNovas

Who invested in MetaNovas?

MetaNovas has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has MetaNovas raised?

MetaNovas has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did MetaNovas last raise money?

MetaNovas's most recent round on record is a Series A, in Mar 2026.

What does MetaNovas do?

, dba MetaNovas, is a drug developer that mainly provides anti-ageing and metabolic drugs.

Where is MetaNovas headquartered?

MetaNovas is headquartered in Shanghai, China.

Which VCs invest in companies like MetaNovas?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at MetaNovas's stage. Their profiles are linked below.

Raising like MetaNovas? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.